Table 2.
Frequency of adverse events of subjects randomized to aspirin and placebo
| Placebo (n = 33) |
Aspirin (n = 32) |
|
|---|---|---|
| Upper respiratory infection | 11 (33.3) | 10 (31.3) |
| Bruising | 8 (24.2) | 8 (25.0) |
| Myalgia | 5 (15.2) | 3 (9.4) |
| Headache | 3 (9.1) | 5 (15.6) |
| Other infections | 4 (12.1) | 4 (12.5) |
| Diarrhea | 4 (12.1) | 3 (9.4) |
| Dyspnea | 4 (12.1) | 2 (6.3) |
| Rash | 3 (9.1) | 3 (9.4) |
| Arthralgia | 3 (9.1) | 3 (9.4) |
| Chest pain | 3 (9.1) | 1 (3.1) |
| Increased transaminases | 3 (9.1) | 1 (3.1) |
| Insomnia | 2 (6.1) | 1 (3.1) |
| Number of bleeding episodes | ||
| Minor | 12 | 11 |
| Major | 1 | 4 |
Data shown as n (%).